Boston Scientific Begins International Clinical Trial Enrollment for INNOVA Self-Expanding Bare-Metal Stent System

Boston Scientific Corporation BSX today announced the start of patient enrollment in the SuperNOVA clinical trial, an international, prospective, single-arm, non-randomized trial evaluating the safety and effectiveness of the INNOVA™ Self-Expanding Bare-Metal Stent System in patients with stenosis of the superficial femoral artery or proximal popliteal artery. Enrollment is planned for up to 300 patients at 50 sites in the U.S., Canada and Europe. The first patient was enrolled in the trial last week by Subhash Banerjee, M.D., Associate Professor of Medicine and Chief of Cardiology at the VA Medical Center in Dallas, TX.